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Granulocyte-Macrophage Colony-Stimulating Factor in the Absence of 
Inflammatory Stimulation: Demonstration by Serum-Free Bioassay, 
Enzyme-Linked Immunosorbent Assay, and Reverse Transcriptase 
Polymerase Chain Reaction 
By Susan C.  Guba, Carolyn 1.  Sartor, Lisa R. Gottschalk, Jing Ye-Hu, Terrence Mulligan, and Stephen G. Emerson 
Bone marrow (BM) stromal fibroblasts produce hematopoi- 
etic  growth factors  (HGFs)  in response to inflammatory 
mediators such as tumor necrosis factor-a or interleukin-la 
(IL-la). In  the absence of such inflammatory stimuli, produc- 
tion of HGFs by BM  stromal cells has been problematic and 
controversial.  In vivo,  however, basal hematopoiesis main- 
tains blood counts within a normal homeostatic range even 
in the absence of inflammation,  and HGFs are required for 
progenitor cell differentiation in  vitro. To better ascertain the 
contribution of BM  stromal fibroblasts to  basal hematopoie- 
sis,  we therefore studied HGF production in quiescent BM 
stromal fibroblasts  by three  sensitive  assays:  serum-free 
bioassay, enzyme-linked immunosorbent assay, and reverse 
transcriptase polymerase chain reaction. Stromal fibroblasts 
EMATOPOIESIS is  a  dynamic, interactive  process  H between developing hematopoietic cells and nonhe- 
matopoietic cells that  comprise  the bone  marrow  (BM) 
stromal microenvironment.  BM  stromal cells provide the 
physical geometry and adhesive niche in which hematopoi- 
etic progenitor  cells differentiate.’-3 Given their intimate 
proximity, stromal cells are likely producers of  hematopoi- 
etic growth factors (HGFs), or colony-stimulating factors 
(CSFs), critical for progenitor cell differentiation. 
Several lines of evidence suggest that these stromal cells 
provide the critical, obligate role for hematopoietic differen- 
tiation in the BM. Although several HGFs can indeed be 
produced by T cells, these do not appear to be essential for 
basal  hematopoiesis.  This is demonstrated  both in nude 
mice,  which  lack  T  cells,  and  in  patients  with  severe 
combined immunodeficiency syndrome (SCID), who lack 
functional T cells. In both models, hematopoiesis appears 
to be normal.4~~  Conversely, previous studies have shown 
that the combination  of  human  serum and nonadherent 
BM cells do not support colony formation unless exogenous 
CSFs were added, whereas unseparated BM mononuclear 
cells do support colony formation without exogenous CSFs.6 
These data support  a role  for BM stromal cells in CSF 
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were cultured in the presence or absence of normal human 
serum to deteimine if serum factor(s) present in the nonin- 
flammatory (basal) state induce secretion of HGFs.  Human 
serum was found to induce or enhance transcription  and 
secretion of granulocyte-macrophage colony-stimulating fac- 
tor (GM-CSF) and enhance secretion of  constitutively ex- 
pressed IL-6. In contrast, no secretion of either granulocyte- 
CSF  (G-CSF) or IL-3 was found.  These data  indicate that 
factors  in normal  human serum  are  active  in enhancing 
GM-CSF  and  IL-6 production  by stromal fibroblasts  and 
suggest that these growth factors contribute  to  the maintain- 
ance of normal, basal hematopoiesis in  vivo. 
o 1992 by The American Society of Hematology. 
production. Thus, stromal cells are required both to pro- 
duce and present growth factors to hematopoietic precur- 
sor cells. 
Although  the cellular  components  of  BM  stroma  can 
indeed be induced to secrete HGFs, their production under 
basal, unstimulated  conditions has proved difficult to de- 
tect. While growth factor production by  both endothelial 
cells and fibroblasts  has  been  well  characterized  under 
inflammatory  conditions,  ie,  in  the  presence  of  tumor 
necrosis  factor  a (TNFa)  or  interleukin-la  (IL-l~t),~-l~ 
production of  growth factors by stromal cells in the absence 
of  such stimuli has not been detected. This dichotomy has 
created  the  apparent  paradox:  How  can  hematopoiesis 
occur  within  the  BM  in  the  absence  of  stromal  HGF 
production? Several investigators have suggested that per- 
haps stromal mesenchymal cells do indeed secrete HGFs, 
but  that  they  do so  in  such  small  quantities  that  local 
presentation of the HGFs by stromal cells to the hematopoi- 
etic progenitor cells is necessary to support basal hematopoi- 
To test whether BM stromal cells produce such low levels 
of  HGFs in the absence of  inflammation would therefore 
require the use of  sensitive methods for detection of  growth 
factors.  Focussing  on  BM  stromal  fibroblasts,  we  have 
therefore  now  used  serum-free  bioassays,  reverse  tran- 
scriptase polymerase chain reaction (rtPCR), and enzyme- 
linked immunosorbent assays (ELISAs) to identify specific 
growth factor production by these cells. Our results show 
that the secretion of  granulocyte-macrophage-CSF  (GM- 
CSF) and IL-6 is stimulated by human serum factors in the 
absence of  inflammation, while granulocyte-CSF (G-CSF) 
and IL-3 secretion by  stromal fibroblasts does not occur in 
vitro in the absence of inflammatory stimuli. 
esis.1-3J4 
MATERIALS AND METHODS 
BM  cells  were  obtained  from  healthy  adult 
volunteer donors, after obtaining informed consent, by aspiration 
into  presewative-free  heparin.  The  procedure  was  performed 
BM  samples. 
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under a protocol approved by the University of  Michigan Human 
Investigations Committee. 
The mononuclear cells were sepa- 
rated by density centrifugation over Ficoll-Hypaque (specific grav- 
ity 1.077) and the stromal cells separated by adherence to plastic. 
The cells were grown to confluence in Iscove's modified Dulbecco's 
medium (IMDM; GIBCO-BRL Laboratories, Grand Island, NY) 
with 10% fetal calf serum (FCS; Hyclone, Logan, UT) and  10% 
equine serum (ES; Hyclone), with nonadherent cells removed after 
48 hours. For most experiments, the adherent layers were passaged 
at confluence. 
Immunohistochemical analyses of multiply passaged monolayers 
were performed on acetone-fixed slides. Antibodies used included 
antLCD2 (pan T cell); CD14, KPI, Mac 387 (monocytelmacro- 
phage); CD19 (pan B cell); CD34 (hematopoietic progenitor cells, 
monocytes); DRC, Sl00 (dendritic reticulum cells); and factor VI11 
(endothelial  cell, megakaryocytes). Immunostaining was  accom- 
plished using a three-step avidin-biotin-peroxidase method, with 
hematoxylin used as a c~unterstain.'~ 
After several passages, 
the  adherent  stromal  layers were  cultured  in  either  IMDM  or 
AIM-V (GIBCO-BRL Laboratories) in the absence of  serum for 
96 hours. Individual flasks of  the stromal layers were then cultured 
in medium supplemented with either 10% to 20% human serum, 
10%  to  20%  FCS,  or  10  ng/mL  recombinant  human  IL-la 
(Genzyme, Boston, MA). CM was collected and frozen for subse- 
quent evaluation by  proliferation assay or ELISA. In some cases, 
either before or after stimulation, the adherent stromal layers were 
incubated with 15 mU of  heparitinase  (ICN Immunobiologicals, 
Lisle, IL) in heparitinase buffer (0.25 mol/L sodium acetate, 0.25 
mol/L calcium acetate, and 0.1% bovine serum albumin [BSA]) at 
43°C for 4 hours.15 Alternatively, conditioned medium collected 
after stimulation of  stromal layers was diluted 1:2 in heparitinase 
buffer and then digested for 4 hours at 43°C. In other cases, 3 hours 
after stimulation the stromal layer was sacrificed and total cellular 
RNA prepared, as described below. 
Aliquots of CM were concentrated 4- to 
10-fold  by centrifugation at 1,OOOg in a 25°C fixed angle JA-17 rotor 
(Beckman, Palo Alto, CA) in Centricon-10 concentrators (Amicon 
Division of  W.R. Grace and Co,  Danvers, MA) until the desired 
volume had been reached. 
The nonadherent BM mononuclear 
cells were enriched for progenitor cells as previously de~cribed.'~." 
Briefly, the cells were incubated with  saturating  quantities of  a 
panel of  eight murine monoclonal antibodies (MoAbs) as follows: 
anti-Leu-1  (with specificities for T cells), anti-Leu 5b (T cells and 
natural killer [NK] cells), anti-leu-10  (HLA-DQ), anti-Leu-M1 
(mature and precursor myeloid and monocytic cells), anti-Leu-12 
(B cells), anti-CALLA (pre-B cells), TG-1 (granulocytes, myeloid 
precursors, and some monocytes), and glycophorin A (erythroid 
cells) for  1 hour  at  4°C.  The cells were  then  thrice washed to 
remove excess antibody. Antibody-negative cells were isolated by 
panning  by  incubating  anti-Ig-coated  plastic  dishes  with  the 
labeled cells for 1  hour at 4°C. The nonadherent antibody-negative 
cells,  enriched  9-  to  20-fold  for  progenitor  cells,  were  then 
recovered and subsequently used in proliferation assays. 
BM mononuclear cells enriched for progen- 
itor cells were plated  in AIM-V at a concentration  of  1 x  105 
cells/well in  quintuplicate in 96-well plates  (Costar, Cambridge, 
MA). The cells were either unstimulated or stimulated with I%, 
lo%, or 20% CM collected as described. The cells were incubated 
for 96 hours at 37°C under 5% COz. During the last 6 hours of the 
incubation, 1  mCi 3H-TdR (Dupont, NEN Products, Boston, MA) 
was added to each well. The cells were harvested using a PHD cell 
harvester  (Cambridge  Technology,  Inc,  Cambridge,  MA)  and 
Stromal layer preparation. 
Stromal cell conditioned medium (CM). 
Concentration  of  CM. 
Progenitor cell enrichment. 
Prolifration assays. 
3H-TdR uptake  measured  by  a Wallac  1410 liquid scintillation 
counter (Pharmacia, Gaithersburg, MD).18 In some experiments, 
cells were  cultured  in  the presence  of  either neutralizing  anti- 
IL-la or anti-IL-lp  antibody  (Genzyme),  added  at  quantities 
sufficient to neutralize 500 U/mL IL-la or IL-lp, respectively. 
ELISAs were  performed  using  the  double-antibody 
sandwich method, using commercially available kits. The cytokines 
tested were IL-3, IL-6, and IL-1 (R & D Systems, Minneapolis, 
MN), G-CSF (Amgen, Thousand Oaks, CA), and GM-CSF (Gen- 
zyme). Based on parallel assays of  known diluted standards, the 
sensitivities of  the  assays  using  unconcentrated  CM  were  as 
follows: IL-3,30 to 2,000 pg/mL; IL-6,30 to 2,000 pg/mL; G-CSF, 
40 to 5,OOO  pg/mL; IL-1,30 to 2,000 pg/mL; and GM-CSF, 2 to 500 
pg/mL. Used in conjunction with concentrated CM, these assays 
were able to detect concentrations as low as: IL-3,3 pg/mL; IL-6,3 
pg/mL; G-CSF, 4 pg/mL; and GM-CSF, 200 fg/mL. To determine 
whether supematant concentration  substantially altered  ELISA 
results,  control  experiments  were  performed  in  which  known 
standards were concentrated and reassayed. In these experiments, 
preconcentration and postconcentration sample assays gave similar 
results 515%. 
RNApreparation.  After appropriate culture, total cellular RNA 
was recovered from BM stromal cells.19  Cells were suspended in 
GITC solution (final concentrations are 4 mol/L guanidine isothio- 
cyanate, 0.5% sarcosyl, 25 mmol/L citric acid, pH 7.0, and 0.007% 
b-mercaptoethanol),  then sequentially mixed with 0.2 mol/L so- 
dium  acetate, pH 4.0,  l vol  phenol,  1/10 vol  49:l  chloroform: 
isoamyl  alcohol,  and  then  cooled  on ice  for  15 minutes.  The 
aqueous layer was extracted and precipitated  at -20°C  in isopro- 
panol. The RNA was  reprecipitated  in equal volumes of  GITC 
solution and isopropanol, dried, and resuspended  in RNAse-free 
water. 
Sense  and  antisense  primers  were 
prepared in the oligonucleotide synthesis core at the University of 
Michigan. The primers used were  as follows: GM-CSF, (nucle- 
otides  100  to  124, sense)  GAGCATGTGAATGCCATCCAG- 
GAG and (nucleotides 415 to 442, antisense) CTCCTGGACTG- 
GCTCCCAGCAGTCAAAm; abl,  (nucleotides  -  150  to -  120, 
sense) CGAGCCGGGCCTGAGCCGGGCCCG GACCGA and 
(nucleotides  63  to  100,  antisense)  TCACTGGGTCCAGC- 
GAGAAGGTT"CCTTGGAGTTzl;  G-CSF, (nucleotides 95 to 
115,  sense)  CACAGTGCACTCTGGACAGTGCAGGAA and 
(nucleotides 480 to 510, antisense) CATTCCCAG'ITCTTCCATC- 
TGCTGCCAGATZ2; IL-6,  (nucleotides  26  to  52,  sense) 
GGATCCTCCTTCTCCACAAGCGCCITCGGT  CCA and (nu- 
cleotides  421  to  450,  antisense)  AAGCTTGTTCCTCACTAC 
TCTCAAATCTGTTCTGU; IL-3, (nucleotides 90 to 120, sense) 
GGATCCTTGAAGACAAGCTGGGTTAACTGCTCTAAC  and 
(nucleotides 339 to 368, antisense) AAGCTTGATATGGATTG- 
GATGTCGCGTGGGTGC";  IL-la,  (nucleotides  121  to  144, 
sense) GGCCCACTCCATGAAGGCTGCATG  and (nucleotides 
766 to 789, antisense) GTCAGTGATAGAGGGTGGCCCCCCZs; 
IL-lp, (nucleotides 121 to 144, sense) CCTTGCCCTCTGGATG- 
GCGGCATC and (nucleotides 541 to 564, antisense) CACGCAG- 
GACAGGTACAGATTCIT.  All  oligonucleotide  primer  pairs 
spanned  intron-exon splice sites, thus  PCR  products generated 
from  any  DNA  present  in  the  RNA  preparations  could  be 
distinguished from those generated after rtPCR. 
RNA, 1.0 kg, lox RT buffer (Ix RT buffer consists of 
50 mmol/L Tris, pH 8.3, 50 mmol/L KCI, 8.0 mmol/L MgCI2, and 
10 mmol/L dithiothreitol), 25 mmol/L dXTP mix (25 mmol/L of 
each  dXTP  [ACGT]),  3.0  pg  oligo  d(T),  and  2.5  U  reverse 
transcriptase (AMV-Reverse Transcriptase, GIBCO-BRL, Gaith- 
ersburg, MD) were incubated at 41°C for 1  hour. One-fifth of  the 
double-stranded product was mixed with lox Taq/RT buffer (1  x 
ELZSA. 
Oligonucleotide primers. 
rtPCR. 
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Taq/RT buffer consists of  10 mmol/L Tris, pH 8.3, 50 mmol/L 
KCI, 1.5 mmol/L MgC12,0.01% gelatin, and 2.0 mmol/L dithiothre- 
itol), 1  mmol/L dXTP mix, 500 ng each of the sense and antisense 
oligonucleotides of interest, and 2.5 U Taq polymerase (AmpliTaq 
DNA polymerase; Perkin Elmer Cetus, Norwalk, CT).  The reac- 
tion mixture underwent thermal cycling at 94°C for 1 minute and 
72°C for 3 minutes for 35 cycles, then finally a 10-minute extension 
at 72°C (Perkin Elmer Cetus DNA Thermal Cycler). PCR products 
were electrophoresed in  agarose visualized  using ethidium bro- 
mide, and gave rise to bands of  the sizes expected for the primers 
used (GM-CSF, 332 nt; G-CSF, 415 nt; IL-6,398 nt; IL-3,278 nt; 
IL-la, 668 nt; abl, 250 nt). 
The cDNA probes used for IL-3, GM-CSF, and 
G-CSF used  resulted from random hexanucleotide labeling with 
32P-dCTP26,27  of  gene-specific inserts (25 ng). The IL-3 probe is a 
1.0-kb Xho I cDNA fragment, the  GM-CSF probe is  a 700-bp 
EcoRI-Hind111 fragment and the G-CSF probe is a 900-bp Xho I 
cDNA fragment. A synthetic IL-6 oligonucleotide was end-labeled 
using polynucleotide kinase and 32P-gATP.28 
The identity of  PCR products 
(GM-CSF  and IL-6) present on agarose gels was confirmed and the 
absence of  signal (G-CSF and IL-3) on  agarose gels was evaluated 
by  alkaline Southern blot analysis. The agarose gel samples were 
transferred  to  nylon  (Zeta-Probe blotting membranes; Biorad, 
Richmond, CA) in 0.4  mol/L NaOH, and then the membranes 
were  hybridized with  the  appropriate  32P-labeled (Amersham, 
Arlington  Heights, IL)  probe. Hybridization to  cDNA  probes 
(GM-CSF, G-CSF, and IL-3) was performed in final concentra- 
tions of  6x standard saline citrate (SSC; lx  SSC is 0.15  mol/L 
NaCl and 0.015 mol/L sodium citrate), 0.5% blotto, 1.0% sodium 
dodecyl  sulfate  (SDS),  0.01  mol/L  EDTA,  and  100  mg/mL 
denatured  sonicated salmon sperm DNA and  probed with  the 
appropriate 32P-labeled  probe. Alternatively, hybridization to an 
IL-6 oligonucleotide  probe was performed in final concentrations 
of 6x NET (lx NET is 0.15 mol/L NaCl, 15 mmol/L Tris, pH 8.0, 
and 1.0 mmol/L EDTA), lox Denhardt’s solution, and 1% SDS. 
Filters were further analyzed by  scanning densitometry using the 
Betascope 603  blot  analyzer (Betagen  Corporation, Waltham, 
MA). 
DNA probes. 
Alkaline Southern blot analysis. 
RESULTS 
To  determine if  confluent,  multiply passaged  stromal 
fibroblasts were  capable  of  producing  any  HGFs under 
conditions emulating basal state, the ability of stromal cell 
CM to stimulate progenitor cell proliferation in serum-free 
bioassays was measured. Confluent BM stromal cells were 
prepared by  multiple (at least 3) passages of  BM adherent 
layers. Whereas primary adherent stromal cells consisted 
largely of fibroblasts, but also included endothelial cells and 
monocytes, multiply passaged  stromal  layers were  essen- 
tially homogeneous fibroblasts, apparently free of contami- 
nating monocytes, endothelial cells, and T and B cells, as 
measured by indirect immunofluorescence. 
Confluent,  multiply  passaged  BM  stromal  cells were 
cultured  in 20%  FCS for 7 days, and the CM collected. 
Highly enriched BM progenitor cells were then cocultured 
in the presence of  either serum-free medium alone or 1%, 
IO%,  or 20% CM, and proliferation of  the progenitor cells 
in  response  to  these  stimuli  was  assayed  by  3H-TdR 
incorporation. Under these conditions, stromal CM stimu- 
lated the proliferation of  highly enriched progenitor cells 
(Fig 1). To control for the serum present in the CM, FCS 
mcu 
DONOR1 [  l0%W 
l%CM 
mcu 
DONOR2 [  l0%CU 
l%CM 
2.0% FCS 
l.O%FCS 
0.1%  FCS 
CELLSALONE 
0  4m  800  800 
cpy 
-I 
Fig 1.  Normal  human BM stromal  fibroblast  CM  stimulates  progen- 
itor cell proliferation. CM was collected from one of two BM stromal 
cell  layers cultured  in  the  presence of  20%  FCS for  7  days.  BM 
mononuclear cells (le)  enriched for progenitor  cells, were cultured in 
100 mL AIM-V either alone or with 1%. 10%. or 20% for 96 hours at 
37°C under 5% Cot. Six hours before  harvesting, 1 mCi of 3H-TdR  was 
added  to  each  culture  well,  and  DNA  synthesis  determined by 
measuring aH  incorporation. In parallel assays,  10 ng/mL OM-CSF 
stimulated  the incorporation of  1,225 2 330 CPM (experiment 1) and 
2,300 f  640 CPM (experiment  2). Results  are presented  as the mean 
SE  of  five  replicates, from data from two of  six  similar  stromal 
monolayer supernatants studied in this bioassay. 
was added in the appropriate  final concentrations to control 
wells. The serum in these final concentrations itself had no 
effect on progenitor  cell proliferation. When the stromal 
cells were cultured in the absence of  serum, this CM did not 
induce  progenitor  cell  proliferation  (data  not  shown). 
These results suggested that multiply passaged BM stromal 
fibroblasts cultured in the presence of  serum stimulate the 
proliferation of hematopoietic progenitor cells. 
To confirm the suggestion that HGFs were produced by 
these stromal layers, total cellular RNA was prepared from 
layers cultured either serum-free or with human serum or 
with or without IL-la. The RNA was amplified by rtPCR 
with  sense  and  antisense  oligonucleotides  for  GM-CSF, 
G-CSF, IL-3, or IL-6 and for the proto-oncogene ab1 as a 
control for the PCR procedure. A positive control for each 
specific oligonucleotide was performed by stimulating stro- 
mal  layers with  IL-la,  known  to induce  the genes  for 
GM-CSF, G-CSF, and IL-6.7-13  In addition, RNA prepared 
by  stimulation  of  peripheral  blood  T cells with phorbol 
myristate  acetate  (PMA)  and  ionomycin served  as  the 
positive control for IL-3.29 As a negative control, the PCR 
reaction was performed with all reagents except the RNA. 
This blank (B) was negative in all cases. 
The results  showed the presence  of  message  for both 
GM-CSF and IL-6. In preliminary studies comparing cyto- 
kine messenger RNA (mRNA) expression between 1 and 
24 hours, we found that maximal message levels were found 
between  3 and 6 hours  after  initiation of  serum-replete 
cultures.  Unless  otherwise  specified,  all  data presented 
here derive from cultures after 3 hours of  incubation in 
serum. Specifically, message for GM-CSF was either found 
to be  stimulated  (in  9  of  17 stromal  layers studied)  or 
augmented (in 8 of  17 stromal layers studied) after stimula- 
tion with human serum. Two such samples, one representa- 
tive  serum-stimulated  message  induction  and  the other 
serum-stimulated amplification, are shown in Fig 2.  These 
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Fig 2.  Stromal fibroblasts accumulate OM-CSF and IL-8 mRNAs. 
Multiply passaged  stromal layers were cultured in  the absence (-)  or 
presence (+) of  20.h  human serum for 3 hours. The stromal layers 
were sacrlflced  and total cellular RNA prepared by the acid phenol 
method."  Oligo dlT)  RNA was amplified by PCR  using sense and 
antisense oligonucleotidesfor abl, GM-CSF, 0-CSF, IL-3, and IL-6. The 
results for two different normal donors are shown in their respective 
panels. Markers (MI are shown. As a negative control, blanks (6)  were 
prepared by mixing all PCR  reagents except the RNA in the initial 
reverse transcriptase step. Two positive controls were performed. 
The proto-oncogene ab1 is constitutively expressed,  and appropri- 
ately present in  all sampler except the blank. The positive control (C) 
corresponds to  use of oligo d(T) RNA known to be positive for the 
growth  factor of interest (sw  text). 
data  suggest  that  GM-CSF gene  transcription  may  be 
constitutive, but at a very  low  level, and thus not  always 
detected. Alternatively,  induction of  the  GM-CSF gene 
may be variably responsive to other factors in the culture. 
Nonetheless, the addition of  human serum to the culture 
results in increased expression of  the GM-CSF transcript 
compared with the unstimulated state. 
To verify that apparent differences in GM-CSF mRNA 
levels detected by  rtPCR  from  basal  and human serum- 
stimulated conditions were reflective of  real differences in 
mRNA levels, serial twofold dilutions of mRNA containing 
known  GM-CSF message were isolated and amplified for 
GM-CSF mRNA by  rtPCR. The results demonstrated that 
this  rtPCR  assay  is  able  to  distinguish  approximately 
fourfold or greater  differences in  mRNA  levels,  over  a 
range  of  31.3  ng  to  2.0  pg  total  RNA,  resulting  in 
comparable signals to those obtained in the basal stromal 
cell rtPCR studies (Fig 3). IL-6 message was detected at 
similar levels in RNA isolated from stromal cells cultured 
both in the presence and absence of  serum. Two represen- 
tative samples are shown (Fig 2). The identity of both the 
GM-CSF and IL-6 transcripts was confirmed by  alkaline 
Southern blot hybridization  with radiolabeled specific cDNA 
or oligonucleotide probes, as described in Materials and 
Methods (Fig4). 
Although these stromal fibroblast monolayers  were appar- 
ently free of monocytes as assayed by  immunocytochemis- 
try, we were concerned that endogenous IL-1  production in 
the  monolayer  cultures might  have  contributed  to  the 
expression of  IL-6  in unstimulated cultures. Assays were 
therefore performed at both  RNA and protein  levels to 
GM-CSF 
b 
I 
IL-6 
L 
I 
Fig 3.  HGF WCR  marumments di.criminate  speclfic mRNA lav- 
01s.  Multiply paasaged stromal layers or peripheral  blood T cells wera 
stimulated with 10 ng/mL IL-la for 3 hours. Total cellular RNA was 
prepared by the acid phenol method and amplified for abl, GM-CSF, 
G-CSF, and IL-6 in the case of the stromal cell RNA and for 11-3 for the 
T-cell RNA. Markers (FC x Haelll) and blanks (6)  are shown. Resub 
represent serial dilutions of total cellular  RNA that then undergo 
rtPCR. In the case of GM-CSF,  G-CSF,  IL-6,  and abl,  the undiluted 
sample (1) represents an rtPCR reaction that started with 2 cg total 
cellular RNA. In the case of IL-3, the undiluted sample (1)  represents 
500 ng  total cellular RNA. 
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Fig 4.  Confirmation of the putative identiy  of PCR products by 
alkaline Southem hybridization. Electrophoresed PCR products were 
transfered to  nylon in  0.4  moIlL  NaOH. GM-CSF, G-CSF,  and 11-3 PCR 
products were  hybridized to their  appropriate UP-cDNA  labeled 
probes;  11-6  was hybridized to  a UP-gATP end-labeled oligonucle- 
otide. Representative samples are shown for each cytokine with (+) 
and without (-1  human serum stimulation. A positive control (C) and 
blank  (B) were  prepared  as  previously described.  Note that the 
identity of GM-CSF and IL-6 PCR products was verifled. Conversely, 
G-CSF  wes  not detected  at  a  110-hour exposure,  except  in the 
positive control. IL-3  was detected at low  level; however, when the 
filter probed with cDNA for IL-3 was analyzed by scanning densitome- 
try, no lane had signal greater than background. In  ail  cases, the blank 
lanes were negative. 
explore this possibility. First, neither IL-la nor IL-1s was 
detectable by  ELISA in supernatants from  a total of  15 
stromal fibroblast monolayers. either  in  the presence or 
absence of serum. Second, inclusion of neither neutralizing 
anti-IL-lp  antibody (Fig 5) nor anti-lL-la  antibody (data 
not  shown) in the stromal cultures did  not  abrogate the 
expression of  IL-6 message, nor did it decrease the amount 
of  IL-6 assayed  by  ELISA  in  the stromal supernatants. 
Finally, neither IL-la nor IL-ls message was detectable by 
rtPCR in either serum-free or serum-rcplete stromal fibro- 
blast RNA (data not shown). 
In contrast  to GM-CSF and  IL-6,  no IL-3 or G-CSF 
transcript from serum-stimulated, multiply  passaged stro- 
mal  fibroblasts  was  detected  by  direct  visualization  of 
ethidium bromide-stained agarose gels (Fig 2). To assess 
the level of visual detection of  IL-3 and G-CSF transcripts, 
serial dilutions of  RNA obtained by  IL-la stimulation of 
stromal fibroblasts (positive controls for G-CSF) or PMA 
and ionomycin stimulation of  T cells (positive controls for 
IL-3) were amplified by  rtPCR (Fig 3). Analyzed  in this 
way, both G-CSF and IL-3 transcripts were detectable to a 
dilution of  1:32, corresponding, respectively, to a total RNA 
dilution to 62.5 ng and 15.6 pg. 
In a further attcmpt to detect stromal fibroblast message 
for IL-3 and G-CSF signal, alkaline Southern blots of  the 
IL-3 and G-CSF agarose gels were prepared. The G-CSF 
alkaline Southern blot demonstrates no G-CSF message at 
a 1  10-hour exposure, confirming that stromal fibroblasts do 
not transcribe G-CSF under unstimulated or human scrum- 
stimulated conditions (Fig 4).  Signal for IL-3 mRNA was 
generally absent, and only appcarcd to be detected once, 
after film exposure for 1.5  hours, in contrast to the T cell 
RNA control, in which  IL-3 message was clearly discern- 
able at 1.5 minutes. Even in this one case, whcn the alkaline 
Southern blots for both G-CSF and IL-3 were additionally 
analyzed  by  scanning densitometry,  no  message  above 
background was  detcctcd  in  cithcr  thc  unstimulatcd or 
serum-stimulated case,  for  either  cytokine. This  photo- 
graph is shown in Fig 4. 
Because the stromal fibroblasts studied in these assays 
had  been enriched by  repetitive passaging from  a mixed 
population of stromal endothelial cells, macrophages, and 
adherent lymphocytes as well as fibroblasts, we  then asked 
whether  G-CSF mRNA  might  be  dctccted from  unpas- 
saged, primary stromal monolayers. In these studies, G-CSF 
mcssage was clearly detected from primary stromal cultures 
SERUM 
M  +C  -c 
Fig 5.  IL.6 mRNA expression in normal BM  fibroblasts cultured in 
the presence or absence of serum, and in  the presence or abwnce of 
anti-IL-lp.  Cells were cultured as described in the figure,  harvested, 
and RNA isolated after 3 hours. 11-6 mRNA was amplified from each 
sample as described in Materials and Methods. A parallel sample, in 
which  primers  and  all reagents,  but without  added  RNA,  were 
subjected  to the  same  reactions  conditions as  the  experimental 
samples, is shown as a negative control lane (C) while IL-6-specific 
RNA from IL-lestimulated stromal cells is shown as  the positive 
control. 
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in the presence of serum, both in the presence and absence 
of  IL-la. However, G-CSF message was not detectable in 
stromal layers cultured under serum-free conditions, even 
from  these  primary monolayers containing multiple cell 
types (Fig 6). 
Specific ELISAs were performed for GM-CSF, G-CSF, 
IL-6, and IL-3 to quantitate the individual growth factors 
present  in  human  serum-stimulated stromal  layer  CM. 
GM-CSF was measured in control (unstimulated), human 
serum-stimulated,  and  IL-la-stimulated  CM,  72  hours 
poststimulation (Fig 7). Two (of 20) representative experi- 
ments arc shown using two different normal donors. GM- 
CSF is present in the unstimulated samples at concentra- 
tions of  0 and 380 fg/mL, in the human serum-stimulated 
samples at concentrations  of 670 and 70  fg/mL, and in the 
IL-la-stimulated samples at  1.45  and  137 pg/mL. These 
low levels of GM-CSF were detected by  ELISAs performed 
on  IO-fold  concentrated CMs and  these values are cor- 
rected for the concentration factor of  the CM. As demon- 
strated for the GM-CSF transcript, the GM-CSF protein 
was sometimes found to be prescnt in unstimulated CM, 
1" BM STROMA 
A'- -  +-  +I  m 
n  FCS 
.-  >  Time 
2  ' 6"  3"  3"  6"  6" '  0 
$  %'-  +  +  +  +'  $5 
x- 
FIg 6.  Pdmary BM stromal layers accumulate G-CSF mRNA in the 
presence of serum,  in  the presence or absence of IL-la Primary BM 
stromal layers,  containing endothelial cells,  monocytes, and other 
adherent cells,  were cultured as  indicated. RNA was isolated from 
each of samples, and G-CSF message was amplified  from each sample 
as in  Fig 2. 
won  1 
OONOA 2 
01  LI 
0  500  lmp  1500  "  137WO 
a-m 
Flg 7.  OM-CSF secretion by normal BM stromal Rbroblasta. GM- 
CSF  was measured by EUSA in CM collected 72 hours after no 
dimulation or stimulation with 20% human serum or 10 ng/mL IL-la 
Results represent duplicates of  two  different stromal layer CM. The 
cultures were maintained at 3pc/s% Cot.  Before performing the 
ELISA, the CM was concentrated 4-  to 10-fold using a Centricon-30. 
The results represent correction  for the concentration  factor. 
but the concentration of  the protein always increased after 
stimulation with human serum. The low  level of  GM-CSF 
protein observed in our experiments was not due to binding 
of the protein to stromal layer glycosaminoglycans such as 
heparan sulfate because digestion of the stromal layers with 
heparitinase, as described in Materials and Methods, did 
not result in elaboration of  increased amounts of  GM-CSF 
(data not shown). 
IL-6 was also detected by  ELISA in supernatants condi- 
tioned  by  stromal  fibroblasts.  Data  from  two  (of  20) 
representative donors are shown (Fig 8). IL-6 levels in the 
unstimulated CM were  1,OOO  and 2,240 pg/mL, and in the 
human serum stimulated CM were 2,100 and 2,680 pg/mL. 
0 
11-6 secretion bv normal BM stromal cells.  IL-6 was mea- 
sured by EUSA in CM &llected  72  hours after no stimulation or 
stimulation with 20% human serum. Results represent duplicates of 
two different normal  stromal layers. The results are corrected for the 
dilution factor. 
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As was found with GM-CSF, stimulation of  stromal fibro- 
blasts  by  human  serum  increased  the  amount  of  IL-6 
protein  detected  in  the  CM,  although  the  amount  of 
stimulation varied among donor samples studied. ELISAs 
for both IL-3 and G-CSF, performed on concentrated CM 
and consistent with the rtPCR data, demonstrated neither 
IL-3 nor G-CSF to be present in the unstimulated or human 
serum-stimulated  CM. In primary stromal monolayer cul- 
tures, however, G-CSF was detectable at between 50 and 
400 pg/mL. 
DISCUSSION 
HGFs are potent molecules that are active in very low 
concentrations. Sensitive analysis of  stromal cells by  PCR 
amplification  of  cytokine  messages  and  CM  by  ELISA 
demonstrates  that  stromal  fibroblasts  do transcribe  and 
secrete CSF at low levels in the femtomolar to picomolar 
range. This emphasizes the importance of the BM microen- 
vironment.  HGFs are produced  and used  locally, where 
local cell-cell contact may serve to maximize the effective 
concentration and effects of  these HGFs. 
Recent studies suggest that one critical HGF produced 
by  stromal cells is the c-kit ligand (also termed stem cell 
factor  [SCF]  or  mast  cell  factor  [MCGF]).3°-32  Normal 
human fibroblasts constitutively secrete this protein, which 
although inactive by itself, synergizes  with other differentia- 
tion-inducing HGFs such as GM-CSF, IL-3, and G-CSF. 
This synergy between c-kit ligand and other more special- 
ized HGFs appears to permit low levels of  these hormones 
to be functionally active. The factors that normally regulate 
the low level, constitutive, in vivo secretion of  these unilin- 
eage and multilineage HGFs are therefore critical in the 
basal regulation of  hematopoiesis in vivo. 
The present study demonstrates that normal human BM 
fibroblasts do indeed secrete both GM-CSF and IL-6 in low 
quantities, even under conditions of basal culture. Stromal 
fibroblast production of  GM-CSF requires the presence of 
human serum for either induction or augmentation of both 
gene expression and protein  secretion. Expression of  the 
GM-CSF gene was variable from person to person in our 
samples. In some cases assayed by  rtPCR, human serum 
stimulation appeared to be required for expression of  the 
GM-CSF gene, while in others human serum stimulation 
augmented gene expression. No differences were identified 
in  the way  cells were  cultured  to explain  this  variable 
GM-CSF expression. For example, all cultures were grown 
using the same lots of  serum. Furthermore,  neither  the 
number of  passages of  the stromal layer nor the medium 
used to starve the cells prestimulation  (IMDM v AIM-V) 
correlated with quiescence or expression of  the gene in the 
absence of  serum. Nonetheless, in all cases cultures in the 
presence of  serum amplified the expression and/or secre- 
tion of  GM-CSF. 
IL-6 appears to be constitutively expressed by  stromal 
layers because it was present in all unstimulated  samples 
tested. However, addition of  human serum to cultures did 
increase  the  amount  of  IL-6  secreted.  Although  it  is 
formally possible  that the presence of  IL-6 mRNA and 
protein was entirely due to stimulation by IL-la or IL-lp, 
we could not find evidence for this interpretation. No IL-1 
was detectable in culture supernatants, and no IL-1 mRNA 
was detectable in fibroblast RNA. While the inclusion of 
anti-IL-1 p appeared to diminish somewhat the expression 
of  serum-induced  IL-6 message, it had no effect on IL-6 
expression  in  serum-deprived  stromal  cells.  Moreover, 
inclusion of  either  anti-IL-la  or anti-IL-1P  antibody  in 
stromal cultures had no effect on measured protein secre- 
tion of  IL-6. These data suggest an important role for IL-6 
in basal hematopoiesis. This role may range from mainte- 
nance of the integrity of  the stromal layer itself to synergism 
with  GM-CSF  for  precursor  cell  development.  Alterna- 
tively, IL-6 may play a permissive role in induction of other 
growth factor genes. 
Quantitation of  IL-6 and GM-CSF protein secreted into 
the CM demonstrates that GM-CSF is present in very low 
concentration (femtograms per milliliter). While one possi- 
bility is that  GM-CSF is effective at this  concentration, 
another is that this concentration is the result of the specific 
experimental procedure used. In our experimental proto- 
col, the stromal layers were pulsed only once with human 
serum or IL-la. The concentration of  GM-CSF detected in 
IL-la-stimulated  cultures from 24 to 84  hours was constant 
(data not shown), suggesting that either GM-CSF is pro- 
duced and consumed at equivalent rates or, alternatively, is 
secreted in response to the initial stimulation, but addi- 
tional GM-CSF is not produced over time. Caldwell et aP3 
have reported that stromal cells pulsed with fresh medium 
transiently  secrete  GM-CSF  at  picograms  per  milliliter 
levels. As discussed by Caldwell et al, diffusion times across 
micron distances for large proteins (10 to 100 Kd) are on 
the order of hours. If  some critical stimulatory proteins are 
rapidly consumed at the boundary layer of  stromal fibro- 
blasts, these cells will  rapidly become  starved in a static 
culture.  Thus,  one  function  of  the  significant  fraction 
(approximately 2% to 5%) of  cardiac output that is deliv- 
ered to BM may be to provide a continuous supply of  the 
requisite stromal cell stimulants.33 
In contrast to IL-6 and GM-CSF, no G-CSF message was 
detected in multiply cultured marrow stromal fibroblasts by 
alkaline Southern blot analysis and no G-CSF was detected 
by ELISA. One possible interpretation of  these data is that 
G-CSF  may  not  play  a  role  in  the  support  of  basal 
hematopoiesis  by  stromal  fibroblasts, but rather is more 
important  under inflammatory  conditions.  Alternatively, 
G-CSF may be important in basal hematopoiesis but may 
be  secreted  by  stromal  monocytes,  a  known  source  of 
G-CSF, or via the interaction of  fibroblasts and monocytes 
within the stromal milieu. This latter interpretation is in 
fact supported by  our data documenting the presence of 
G-CSF mRNA in complex stromal monolayers,  and the 
presence of  small quantities of  G-CSF secreted  by  such 
monolayers. Similar support is provided by  the studies of 
Migliaccio  et  aP4 demonstrating  that  complex  stromal 
monolayers  containing  both  fibroblasts  and  monocytes 
secrete a bioactivity consistent with G-CSF. Alternatively, 
however, the bioassay used by  Migliaccio et a1 could have 
been detecting the activity of a cross-reacting molecule. 
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Very little if  any IL-3 message was detected by alkaline 
Southern blot,  consistent  with  previously reported data. 
Barge et aP5 reported that IL-3 transcript and protein was 
detectable in normal BM stroma. However, they reported 
that the IL-3 was only detected in stromal layers containing 
CD2+CD3c+  or CD2-CD3c+ cells, corresponding to ma- 
ture or immature T cells. In CD2-CD3e-  stromal layers, no 
IL-3 message was detected.  In the present  studies with 
multiply passaged normal human BM fibroblasts, no densi- 
tometry  signal above  background  was  detected,  and  no 
secreted IL-3 protein was detected. Thus, if IL-3 is involved 
in basal  hematopoiesis,  it appears likely that it  must be 
derived from T-lymphoid lineage cells that either circulate 
into the marrow  microenvironment  or secrete  IL-3 at a 
distance. Of  note, however, two lines of  evidence suggest 
that such T-cell signals are unlikely to be essential for basal 
hematopoiesis.  First, hematopoietic recovery after alloge- 
neic BM transplantation  occurs despite the fact that the 
recovering T cells are extremely defective in their ability to 
secrete  HGFs and stimulate  progenitor  cell  differentia- 
ti0n.3~~~~  Second, neonatal  T cells likewise fail to secrete 
HGFs to normal stimuli, apparently due to their develop- 
mental immat~rity.~~ 
In  summary, we  have  shown that normal  human  BM 
stromal fibroblasts  secrete GM-CSF and IL-6 when  cul- 
tured in the presence of  serum, in the absence of inflamma- 
tory cytokines such as IL-la. These data not only support 
the importance of stromal cells in basal hematopoiesis, but 
indeed suggest an obligate requirement for the cytokines in 
basal hematopoiesis. In contrast, G-CSF and IL-3 are not 
secreted by unstimulated or human serum-stimulated stro- 
mal fibroblasts, suggesting that G-CSF and IL-3 are either 
not involved in basal hematopoiesis or are secreted by cells 
(eg, monocytes, T cells) not present in multiply passaged 
stromal fibroblast cell cultures. Finally, some human serum 
factor is required for induction or augmentation of  GM- 
CSF expression and secretion. Similarly, augmentation of 
IL-6  secretion  occurs  in  the presence  of  human  serum 
stimulation. Perhaps the high flux, pulsatile delivery of this 
human  serum factor  in vivo  provides  the stimulation  to 
maintain ongoing, basal hematopoiesis. These studies thus 
document  the production  of  cytokines by  stromal  fibro- 
blasts  in  the absence of  inflammatory  stimuli,  and thus 
provide an explanation for the maintainance of BM hemato- 
poiesis in the basal state. 
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